Business Segments

6 Months Ended

Jul. 03, 2021

Segment Reporting [Abstract]

Business Segments

12. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

	Three Months Ended				Six Months Ended
(in thousands)	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Cyclo G6	$	3,599	$	2,113	$	6,948	$	5,036
Retina		7,575		2,608		14,235		6,742
Other(1)		2,252		1,498		4,202		3,462
Total revenues	$	13,426	$	6,219	$	25,385	$	15,240
(1) Includes service contract revenues of $375 and $311 and $674 and $627 recognized during the three and six months ended July 3, 2021 and June 27, 2020, respectively. Includes $111 recognized revenue related to the exclusive distribution rights during the three and six months ended July 3, 2021. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Six Months Ended
(in thousands)	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
United States	$	6,508	$	3,171	$	12,072	$	7,612
Asia/Pacific Rim		3,280		1,410		6,454		3,603
Europe		3,243		1,419		5,660		3,403
Rest of Americas		395		219		1,199		622
Total revenues	$	13,426	$	6,219	$	25,385	$	15,240

Revenues are attributed to countries based on the location of end customers.

Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the three and six months ended July 3, 2021, representing 12% and 14%, respectively. Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three months ended June 27, 2020 and Japan accounted for more than 10% of the Company’s revenues during the six months ended June 27, 2020, representing 12%. The United States accounted for 48.5% and 51.0% of revenues for the three months ended July 3, 2021 and June 27, 2020, respectively, and for 47.6% and 49.9% of revenues for the six months ended July 3, 2021 and June 27, 2020, respectively.